Skip to main content

Advertisement

SpringerLink
Log in

Molecular Profiling of Parathyroid Hyperplasia, Adenoma and Carcinoma

  • Research
  • Published:
Pathology & Oncology Research

Abstract

The objective of the study was to examine proliferation and apoptosis associated gene expression in the whole sequence parathyroid lesions to reveal specific features of carcinoma. This study was based on surgically removed parathyroid tissues, gene expression analysis was performed both at gene and protein level. First, mRNA isolation was performed from deep-frozen tissue samples, and further apoptosis pathway-specific cDNA macroarray analysis was carried out. The results were validated with real-time PCR. Subsequently, protein expression was analyzed with immunhistochemistry on Tissue Micro Array multi-blocks derived from several paraffin-embedded samples. cDNA macroarrays revealed elevated expression of both pro-apoptotic (FAS receptor, TRAIL ligand, CASPASE8, and −4) and anti-apoptotic (cIAP1, APOLLON) genes in benign proliferative lesions compared to that in normal gland. TMA studies showed overexpression of KI67, P53, SURVIVIN and APOLLON protein and failure of expression of P27, BCL2, BAX, CHROMOGRANIN-A, SYNAPTOPHYSIN, CYCLIND1, FLIP, TRAIL, CK8, CK18, CK19 in parathyroid carcinoma was detected. These alterations in gene expression of the investigated products could be used in differentiation between beningn and malignant proliferative processes of the parathyroid gland. Authors conclude that a series of alterations in gene expression such as overexpression of APOLLON, P53, KI67 and suppression of P27, BCL2, BAX lead to uncontrolled cell proliferation, but still not leading to increased apoptotic activity in parathyroid carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Fernandez-Ranvier GG, Khanafshar E, Jensen K et al (2007) Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110(2):255–264

    Article  PubMed  Google Scholar 

  2. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17 Suppl 2:N18-23

  3. Marx SJ (2000) Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863–1875

    Article  PubMed  CAS  Google Scholar 

  4. Fernandez-Ranvier GG, Khanafshar E, Tacha D et al (2009) Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer 115(2):334–344

    Article  PubMed  Google Scholar 

  5. Stojadinovic A, Hoos A, Nissan A et al (2003) Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol 34(1):54–64

    Article  PubMed  Google Scholar 

  6. Szende B, Farid P, Végso G et al (2004) Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathol Oncol Res 10(2):98–103

    Article  PubMed  CAS  Google Scholar 

  7. Vargas MP, Vargas HI, Kleiner DE et al (1997) The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 10(1):12–17

    PubMed  CAS  Google Scholar 

  8. Hadar T, Shvero J, Yaniv E et al (2005) Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol Oncol Res 11(1):45–49

    Article  PubMed  Google Scholar 

  9. Szende B, Arvai K, Peták I et al (2006) Changes in gene expression in the course of proliferative processes in the parathyroid gland. Magy Onkol 50(2):137–140

    PubMed  Google Scholar 

  10. Solcia E, Kloppel G, Sobin LH (2000) Histological typing of endocrine tumours; international histological classification of tumours. WHO Ed. 2. Springer; p.48–55

  11. Shane E, Bilezikian JP (1982) Parathyroid carcinoma: a review of 62 patients. Endocr Rev 3(2):218–226

    Article  PubMed  CAS  Google Scholar 

  12. Favia G, Lumachi F, Polistina F et al (1998) Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg 22(12):1225–1230

    Article  PubMed  CAS  Google Scholar 

  13. Hundahl SA, Fleming ID, Fremgen AM et al (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. Cancer 1;86(3):538–44

    Google Scholar 

  14. Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26(8):716–726

    Article  PubMed  Google Scholar 

  15. Haven CJ, Howell VM, Eilers PH et al (2004) Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 64(20):7405–7411

    Article  PubMed  CAS  Google Scholar 

  16. Woodard GE, Lin L, Zhang JH et al (2005) Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 10;24(7):1272–6

    Google Scholar 

  17. Cetani F, Pardi E, Ambrogini E et al (2007) Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr Relat Cancer 14(2):493–499

    Article  PubMed  CAS  Google Scholar 

  18. Iacobone M, Masi G, Barzon L et al (2009) Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg 394(5):817–825

    Article  PubMed  Google Scholar 

  19. Yang Y-J, Han J-W, Youn H-D et al (2010) The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res 38:382–390

    Article  PubMed  CAS  Google Scholar 

  20. Masi G, Barzon L, Iacobone M et al (2008) Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer 15(4):1115–1126

    Article  PubMed  CAS  Google Scholar 

  21. Shih RY, Fackler S, Maturo S et al (2009) Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation. Endocr Pract 15(6):567–572

    Article  PubMed  Google Scholar 

  22. Cetani F, Ambrogini E, Viacava P et al (2007) Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol 156(5):547–554

    Article  PubMed  CAS  Google Scholar 

  23. Howell VM, Gill A, Clarkson A et al (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94(2):434–441

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant of the Hungarian National Science and Research Foundation (OTKA T46665) grant. The authors would like to thank Tibor Vaszkó for his valuable comments to improve the manuscript.

Declaration of interest

The authors confirm that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, 1085, Budapest, Hungary

    Kristóf Árvai, Katalin Nagy, Helga Barti-Juhász, István Peták, Tibor Krenács, Tamás Micsik & Béla Szende

  2. Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary

    Gyula Végső & Ferenc Perner

Authors
  1. Kristóf Árvai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katalin Nagy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helga Barti-Juhász
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. István Peták
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tibor Krenács
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tamás Micsik
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gyula Végső
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ferenc Perner
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Béla Szende
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Béla Szende.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Árvai, K., Nagy, K., Barti-Juhász, H. et al. Molecular Profiling of Parathyroid Hyperplasia, Adenoma and Carcinoma. Pathol. Oncol. Res. 18, 607–614 (2012). https://doi.org/10.1007/s12253-011-9483-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-011-9483-7

Keywords

Search

Navigation